NeuroSearch demonstrates the potential of ACR16 as a novel treatment for Huntington’s disease

Today, NeuroSearch presents data on the mode of action and the preclinical pharmacology of ACR16, demonstrating the unique functional activity of the company’s novel drug candidate in development for Huntington’s disease.

http://www.pipelinereview.com/index.php/2009042926657/Small-Molecules/NeuroSearch-demonstrates-the-potential-of-ACR16-as-a-novel-treatment-for-Huntingtons-disease.html